EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions

Diane M Harper, Tamera Paczos, Ruediger Ridder, Warner K Huh

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35353 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Diane M Harper und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Cyclin-Dependent Kinase Inhibitor p16, Ki-67 Antigen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

p16/Ki‐67 dual stain is a biomarker‐based test that can identify oncogenic transformation in cervical cells with higher sensitivity than cervical cytology, using the same samples taken for human papillomavirus (HPV) testing and liquid‐based cytology. Dual stain is approved by the US Food and Drug Administration (FDA) for triage of women with positive results by primary HPV testing or by HPV/cytology co‐testing and has recently been incorporated into management guidelines. In this review, we summarize the data showing the utility of dual stain in detecting precancers, reducing the number of unnecessary colposcopies, and reassuring women who test negative. We also discuss the implications of dual stain for future treatment practice and health economics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsCyclin-Dependent Kinase Inhibitor p16Ki-67 AntigenPrecancerous ConditionsUterine Cervical DysplasiaHumansFemaleTriagePapillomaviridaeBiomarkers, TumorEarly Detection of Cancer

Stichwörter der Autor:innen

HPVcervical cancer screeningdual staintriage

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Ki-67 AntigenCDKN2A protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • University of Michigan, Ann Arbor, Michigan, USA.
  • BronxCare Health System, Bronx, New York, USA.
  • Roche Diagnostics GmbH, Mannheim, Germany.
  • University of Alabama at Birmingham, Birmingham, Alabama, USA.

Förderung

  • NCI NIH HHS
  • Roche

Zitieren

APA

Harper, D. M., Paczos, T., Ridder, R., & Huh, W. K. (2025). p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions. International Journal of Cancer. https://doi.org/10.1002/ijc.35353

Vancouver

Harper DM, Paczos T, Ridder R, Huh WK. p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions. International Journal of Cancer. 2025. doi:10.1002/ijc.35353

BibTeX
@article{Harper2025,
  author = {Harper, Diane M and Paczos, Tamera and Ridder, Ruediger and Huh, Warner K},
  title = {p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35353}
}
Kostenlos starten →